SLS Competitors & Alternatives
Compare Sellas Life Sciences Group Inc with similar stocks in the same industry
Biotechnology
SLS
Main Stock$8.23
Tradestie Score
59
Market Cap
$211.22M
Revenue Growth
-0.8%
Analyst Upside
+21.5%
Top Competitors
226 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OCUL
Ocular Therapeutix, Inc.
|
$8.25
|
$1.92B | - | 58 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$88.28
|
$1.92B | - | 56 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$61.85
|
$1.90B | 367.9 | 60 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$32.29
|
$1.84B | - | 55 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$28.29
|
$1.81B | - | 59 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$5.62
|
$1.78B | - | 58 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$17.04
|
$1.78B | - | 59 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$15.78
|
$1.74B | - | 58 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$28.62
|
$1.68B | - | 54 | Compare |
|
MNKD
Mannkind Corporation
|
$3.40
|
$1.65B | - | 55 | Compare |
More SLS Analysis
Data updated: Jun 06, 2026 | Industry: Biotechnology (SIC 2834)
226 stocks in this industry